国家: 亚美尼亚
语言: 英文
来源: Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում
cetirizine (cetirizine dihydrochloride)
Aesica Pharmaceuticals S.r.l.
R06AE07
cetirizine (cetirizine dihydrochloride)
10mg
tablets film-coated
(7/1x7/) blister
OTC
Registered
2017-10-10
SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE MEDICINAL PRODUCT Zyrtec 10 mg, film-coated tablets Zyrtec 10 mg/ml oral drops, solution 2. QUALITATIVE AND QUANTITATIVE COMPOSITION _Cetirizine dihydrochloride, 10 mg, film-coated tablet _ Each film-coated tablet contains 10 mg of cetirizine dihydrochloride. _Cetirizine dihydrochloride, 10 mg/ml, oral drops, solution _ Each 1 ml contains 10 mg of cetirizine dihydrochloride. 3. PHARMACEUTICAL FORM _Cetirizine dihydrochloride, 10 mg, film-coated tablet _ White, oblong, film-coated tablet, with a bisect line and Y-Y logo. _Cetirizine dihydrochloride, 10 mg/ml, oral drops, solution _ Clear and colourless liquid. 4. CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS For the relief of: - nasal and ocular symptoms of seasonal and perennial allergic rhinitis, - symptoms of chronic idiopatic urticaria. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION ADULTS 10 mg (20 drops or 10 ml of oral solution or 1 tablet or 1 capsule) once daily. A 5 mg starting dose (10 drops or 5 ml of oral solution or half of the tablet) may be proposed if this leads to satisfactory control of the symptoms. CHILDREN _Children aged from 2 to 6 years _ 2.5 mg (5 drops or 2.5 ml of oral solution) twice daily. _Children aged from 6 to 12 years _ 5 mg (10 drops or 5 ml of oral solution or half of the tablet) twice daily. _Children over 12 years of age _ 10 mg (20 drops or 10 ml of oral solution or 1 tablet or 1 capsule) once daily. ELDERLY Data does not suggest that the dose needs to be reduced in elderly subjects provided that the renal function is normal. _Patients with moderate to severe renal impairment _ Since cetirizine is mainly excreted via renal route, in cases no alternative treatment can be used, the dosing intervals must be individualised according to renal function. Refer to the following table and adjust the dose as indicated. To use this dosing table, an estimate of the patient’s creatinine clearance (CLcr) in ml/min is needed. The CLcr (ml/min) may be estimated from serum creatinine (mg/dl) d 阅读完整的文件